Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL‐LM

Author:

Volet Corentin1,Puricel Serban1,Cook Selma T.1,di Cicco Philippe1,Faucherre Yannick1ORCID,Arroyo Diego1,Togni Mario1,Cook Stéphane1

Affiliation:

1. Cardiology University & Hospital Fribourg Fribourg Switzerland

Abstract

AbstractBackgroundOptimal stent deployment in left main (LM) bifurcation is paramount, and incomplete stent apposition may cause major adverse cardiac events (MACE). Bench studies show that the proximal optimization technique (POT) provides the best stent apposition.AimsWe aimed to investigate the impact of POT on clinical outcomes in patients treated for unprotected LM (ULM) disease at our institution.MethodsWe identified 162 patients who underwent percutaneous coronary intervention (PCI) for ULM coronary disease in the Cardio‐FR database. Out of these, 99 (61%) had undergone POT, while 63 patients were treated without POT. The primary outcome was the bifurcation‐oriented composite endpoint (BOCE) of cardiac death, target‐bifurcation myocardial infarction and target‐bifurcation revascularization at maximal follow‐up.ResultsMean age was 76 years, and 69% presented with acute coronary syndrome. Mean follow‐up was 2.25 years (822 days). The BOCE occurred in 43 (27%) of which 20 (20%) in the POT group and 23 (37%) in the no‐POT group (p = 0.009). Cardiac death occurred in 15 (15%) patients in the POT‐ and 17 (27%) in no‐POT group (p = 0.26). Target bifurcation revascularization occurred in 4 (4%) patients in the POT‐ and 6 (10%) patients in the no‐POT group (p = 0.19). POT In the multivariate analysis, POT was the strongest parameter and was associated with BOCE, cardiac death, occurrence of any revascularization and all‐cause mortality.ConclusionThe POT improves clinical outcomes. These findings strongly support the systematic use of POT in patients undergoing ULM‐PCI.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3